|
1）Nakae S, Komiyama Y, Yokoyama H, et al. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int Immunol. 2003; 15（4）: 483-90
|
|
|
|
2）Schmitz N, Kurrer M, Kopf M. The IL-1 receptor 1 is critical for Th2 cell type airway immune responses in a mild but not in a more severe asthma model. Eur J Immunol. 2003; 33（4）: 991-1000
|
|
|
|
|
|
3）Ewart SL, Kuperman D, Schadt E, et al. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol. 2000; 23（4）: 537-45
|
|
|
|
|
|
4）Yoshimoto T, Tsutsui H, Tominaga K, et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci U S A. 1999; 96（24）: 13962-6
|
|
|
|
|
|
5）Yoshimoto T, Mizutani H, Tsutsui H, et al. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nat Immunol. 2000; 1（2）: 132-7
|
|
|
|
|
|
6）Black RA, Kronheim SR, Merriam JE, et al. A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta. J Biol Chem. 1989; 264（10）: 5323-6
|
|
|
|
|
|
7）Cerretti DP, Kozlosky CJ, Mosley B, et al. Molecular cloning of the interleukin-1 beta converting enzyme. Science. 1992; 256（5053）: 97-100
|
|
|
|
|
|
8）Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.Nature. 1992; 356（6372）: 768-74
|
|
|
|
|
|
9）Hofmann K, Bucher P, Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci. 1997; 22（5）: 155-6
|
|
|
|
|
|
10）Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10（2）: 417-26
|
|
|
|
|
|
11）Agostini L, Martinon F, Burns K, et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity. 2004; 20（3）: 319-25
|
|
|
|
|
|
12）Mariathasan S, Weiss DS, Newton K, et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006; 440（7081）: 228-32
|
|
|
|
|
|
13）Lamkanfi M, Dixit VM. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev. 2009; 227（1）: 95-105
|
|
|
|
|
|
14）Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature. 1997; 386（6625）: 619-23
|
|
|
|
|
|
15）Talabot-Ayer D, Lamacchia C, Gabay C, et al. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem. 2009; 284（29）: 19420-6
|
|
|
|
|
|
16）Hoffman HM, Mueller JL, Broide DH, et al. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001; 29（3）: 301-5
|
|
|
|
|
|
17）Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet. 2002; 71（1）: 198-203
|
|
|
|
|
|
18）French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet. 1997; 17（1）: 25-31
|
|
|
|
|
|
19）Richards N, Schaner P, Diaz A, et al. Interaction between pyrin and the apoptotic speck protein （ASC） modulates ASC-induced apoptosis. J Biol Chem. 2001; 276（42）: 39320-9
|
|
|
|
|
|
20）Yu JR, Leslie KS. Cryopyrin-associated periodic syndrome: an update on diagnosis and treatment response. Curr Allergy Asthma Rep. 2011; 11（1）: 12-20
|
|
|
|
|
|
21）Hitomi Y, Ebisawa M, Tomikawa M, et al. Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma. J Allergy Clin Immunol. 2009; 124（4）: 779-85 e776
|
|
|
|
|
|
22）Brickey WJ, Alexis NE, Hernandez ML, et al. Sputum inflammatory cells from patients with allergic rhinitis and asthma have decreased inflammasome gene expression. J Allergy Clin Immunol. 2011; 128（4）: 900-3
|
|
|
|
|
|
23）Eisenbarth SC, Colegio OR, O’Connor W, et al. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008; 453（7198）: 1122-6
|
|
|
|
|
|
24）Franchi L, Núñez G. The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1beta secretion but dispensable for adjuvant activity. Eur J Immunol. 2008; 38（8）: 2085-9
|
|
|
|
|
|
25）Besnard AG, Guillou N, Tschopp J, et al. NLRP3 inflammasome is required in murine asthma in the absence of aluminum adjuvant. Allergy. 2011; 66（8）: 1047-57
|
|
|
|
|
|
26）Ather JL, Ckless K, Martin R, et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol. 2011; 187（1）: 64-73
|
|
|
|
|
|
27）Kool M, Willart MA, van Nimwegen M, et al. An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma.Immunity. 2011; 34（4）: 527-40
|
|
|
|
|
|
28）Allen IC, Jania CM, Wilson JE, et al. Analysis of NLRP3 in the development of allergic airway disease in mice. J Immunol. 2012; 188（6）: 2884-93
|
|
|
|
|